Streetwise Reports' Article Archives — April 2019 back to current month (17)

Firm's AR E-Commerce Solutions to Be Marketed, Sold to Dispensaries (04/29/2019)

With the signing of a reseller agreement, the tech firm continues to penetrate Canada's burgeoning legal cannabis industry.


'Undervalued' Biopharma Features Robust Pipeline, Future Upside (04/24/2019)

The case for investing in this company was made in an H.C. Wainwright & Co. report.


Health Tech Firm to Pilot Artificial Intelligence-Powered Patient Monitoring Tool (04/24/2019)

This effort is one way the company can innovatively offer patients care.


California Gold Mining Full Speed Ahead in Hemp (04/18/2019)

Peter Epstein of Epstein Research provides an update on a mining exploration company that is diversifying into the hemp market.


Health Technology Firm Aims to Extend Reach into Global Medical Cannabis Industry (04/17/2019)

This company is targeting geographies where the cannabis market is growing rapidly.


Analyst: Biopharma, Now Stronger Than Ever, Is an Ideal Takeout Target (04/17/2019)

An argument is made in a ROTH Capital Partners report for a potential imminent deal involving this drug maker.


Developer of Cannabinoid-Based Drugs to Resume Cancer Pain Trial (04/17/2019)

Calling this latest development "excellent news," Paradigm Capital has raised its target price on the company's stock.


Immunotherapeutic Agent Shows Efficacy in Rare Respiratory Disease (04/10/2019)

Trial results for this therapeutic, and their implications for this biotech, were discussed in an H.C. Wainwright & Co. report.


Augmented Reality Firm Moves into Medical Devices Arena (04/09/2019)

This technology company continues to diversify the end markets for its e-commerce platform.


Canadian Tech Firm Secures Largest Contract to Date (04/06/2019)

The new client, in the U.S., is a state governmental agency.


Biotech Achieves Development Milestone for Blue Light Imaging System (04/05/2019)

The surgical imaging firm continues to advance its first medical device toward commercialization.


Canadian Life Sciences Firm Seeks Collaborative Cannabis Partner (04/05/2019)

This represents the company's expansion into another business area.


Innovative Healthcare Tech Firm to Acquire Two Vancouver Pharmacies (04/03/2019)

The transaction will allow the company to add a prescription fill and fulfillment component to its telemedicine app.


Biopharma Expects Data Readouts in Psoriasis, NASH in H2/19 (04/03/2019)

Two recently launched clinical trials, and related conference calls, were reviewed in an H.C. Wainwright & Co. report.


CBD Firm Tallies Strong Q4/18 Performance, 2019 Outlook (04/03/2019)

A ROTH Capital Partners report reviewed the numbers for 2018 and explained why this Colorado-based company should perform well this year.


Cannabis Beverages, Edibles Company Receives Key Permit (04/03/2019)

This represents a major milestone for the firm on its path to commercializing its products.


Best-of-Breed Hemp/CBD Producers (04/02/2019)

Fincom Investment Partners surveys the hemp-CBD landscape and discusses two companies it believes are "best of breed."


More Archives

2024Jun May Apr Mar Feb Jan

2023Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec

2022Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec

2021Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec

2020Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec

2019Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec

Get Our Streetwise Reports' Life Sciences Report Newsletter Free and be the first to know!

A valid email address is required to subscribe

Notable Quotes